Of 34 patients scheduled for aortocoronary bypass operations who were withdrawn from chronic propranolol therapy between 18 and 48 hours before anesthesia and operation, propranolol was detected in the plasma of nine and in atrial tissue of five patients. Higher plasma levels were associated with higher propranolol intake and with shorter time of withdrawal. In 15 patients withdrawn preoperatively from propranolol the heart rate and blood pressure response to 3 gtg isoproterenol was not significantly different from the response of similar patients who had received no propranolol. In contrast to the response of healthy subjects, most patients with coronary artery disease responded to isoproterenol with a decrease in systolic blood pressure. Plasma propranolol levels after a 0.5 mg bolus given intravenously during operation produced a peak level of 40 ng/ml in one minute and disappeared in five minutes. These studies suggest that no beta blockade persists 18 hours after acute preoperative withdrawal of propranolol in patients taking up to 300 mg per day for control of angina. In view of the reported hazards of abrupt withdrawal of propranolol before operation and the reported usefulness of propranolol in treating tachyarrhythmias during operation, we suggest that early preoperative withdrawal of propranolol may be more hazardous than its continuation before coronary bypass operations.
W HEN DENERVATED HEARTS in vitro are exposed to general anesthetics all indices of myocardial contractility are depressed in a doserelated fashion.' For some anesthetics this effect is antagonized in vivo by central sympathetic stimulation. However, the nonflammable anesthetics commonly used during cardiac surgery (halothane, methoxyflurane, and intravenous narcotics) evoke little sympathetic stimulation.2 Concern has therefore been properly expressed regarding the safety of administering general anesthesia to patients who received propranolol preoperatively and the safety of administering propranolol to anesthetized patients. During anesthesia, propranolol might be expected to interfere with cardiac compensatory responses to blood loss, to rapid administration of intravenous fluids, to changes in body position and temperature. Some have therefore recommended withdrawal of propranolol for as long as fourteen days before any anesthetic3 despite the hazard of acute myocardial infarction upon abrupt withdrawal of the drug. 4 5 Our clinical experience with patients chronically receiving propranolol has been contrary to these expectations. We observed that preoperative withdrawal occasionally precipitated serious ventricular arrhyth-mias which were most easily controlled by propranolol, that all patients who had taken propranolol preoperatively were responsive to isoproterenol during operation and that propranolol is a useful, safe antiarrhythmic during cardiac operations. In the only study specifically addressed to the questions of optimal time of preoperative withdrawal of propranolol Faulkner et al.6 failed to find propranolol in the plasma or atrial tissue of eight patients withdrawn from propranolol for 36-48 hours. While supporting our clinical observations, they recommended 48 hours as sufficient for discontinuing propranolol before anesthesia.
To document our clinical observations, we investigated the persistence of measurable propranolol in the plasma and atrial tissue of one group of patients following drug withdrawal. We then tested the residual beta blockade with isoproterenol in a second similar group of patients and we measured the disappearance rate of plasma propranolol after single intravenous doses used to treat arrhythmias during anesthesia in a third group of patients. Methods
Thirty-two patients who had taken various amounts of propranolol by mouth for at least four weeks were studied initially. All were scheduled to undergo aortocoronary saphenous vein bypass graft operations for angina and all had discontinued propranolol within 48 hours of their scheduled operations. Arterial blood was sampled in heparinized syringes just before induction of anesthesia and right atrial tissue was sampled just before cardiopulmonary bypass. Atrial tissue was weighed and thoroughly homogenized. Atrial and plasma samples were assayed for propranolol by the method of Shand et al. 7 By this method values for propranolol-free plasma were consistently less than 5 ng/ml. When propranolol was added to normal plasma to yield final concentrations of 10-100 ng/ml recoveries were 83 ± 3% of calculated concentrations. All determinations were done in duplicate and mean values were reported. Patients received pentobarbital, morphine and scopolamine as preanesthetic medication before arterial blood was sampled. In addition they received morphine, nitrous oxide and pancuronium as the general anesthetic before atrial tissue was sampled. Daily doses of propranolol and the exact time of the last dose were obtained by preoperative interview. At the time of study no patient had taken propranolol within 18 hours.
To determine the degree of beta blockade associated with the blood levels found in the initial group, the heart rate and blood pressure response to a standard dose of isoproterenol was studied in a second group of 45 patients consisting of three subgroups of 15 patients each. Subgroup I consisted of patients similar to those described above. Subgroup II consisted of patients scheduled for aortocoronary bypass who had never taken propranolol. Subgroup III included patients without heart disease who were scheduled for noncardiac operations such as cholecystectomy, herniorrhaphy, or rib resection. All patients were studied in the immediate preoperative period during continuous ECG and intraarterial pressure monitoring. All patients were given isoproterenol 3 ,ig as a bolus intravenously. In all patients the initial response to isoproterenol appeared within 40 seconds and was largely dissipated within four minutes. Peak changes in heart rate, systolic and diastolic pressures were obtained from the continuous trace recorded. Plasma propranolol levels were measured in patients who had received it.
The rate of propranolol disappearance from the plasma and uptake by the atrium following an intravenous bolus dose of propranolol was studied in an additional group of 24 patients. The study was designed to simulate the use of propranolol to treat arrhythmias during cardiac operations Typical response to 3 ug isoproterenol given intravenously to a patient without hedrt disease. A transient increase in heart rate and systolic blood pressure and a decrease in diastolic pressure constituted the typical response.
propranolol the difference was not significant in terms of frequency or degree of change in systolic pressure. Figure 2 Atypical response to 3 gg isoproterenol given intravenously to a patient with coronary artery disease just before induction of anesthesia for aortocoronary bypass operation. Although heart rate increased and diastolic pressure decreased, systolic blood pressure also decreased. This response was seen in 20 of 30 patients with coronary artery disease. Coltart and Shand9 in studies of healthy subjects found that maximum blocking of exercise tachycardia occurred at plasma propranolol levels of 40 ng/ml after oral administration and 100 ng/ml after intravenous administration. They also found in these subjects that propranolol levels of 10-20 ng/ml after intravenous administration blocked only 20-30% of exercise-induced tachycardia. Based on these observations of blocking effects related to plasma propranolol levels, it is difficult to attach much clinical significance to the plasma propranolol levels observed in our patients withdrawn from propranolol less than 24 hours (tables 1 and 2). Plasma propranolol greater than 20 ng/ml was observed in only one patient tested with isoproterenol. His intake had been 300 mg per day by mouth and isoproterenol produced a normal heart response but an atypical systolic pressure response. It would seem from these data that concern over persisting beta blockade after withdrawal of oral propranolol need arise only in patients taking larger doses and withdrawn a shorter period than our patients. Our data also suggest that any questions concerning persisting blocking effects could be resolved by administering 3 gg isoproterenol and measuring the heart response. Our finding of a normal heart rate response to isoproterenol in patients with plasma propranolol levels up to 23 ng/ml indicates that if excessive bradyeardia or hypotension from propranolol occurred during general anesthesia, these effects could be readily antagonized by an appropriate dose of isoproterenol.
The poor correlation between propranolol content of the atrium and either plasma levels or propranolol intake was disappointing. We have no explanation other than perhaps the lack of uniformity in site and quantity of tissue sampled in this clinical setting, a variable not readily controlled.
The atypical response (decreased systolic pressure) after isoproterenol which occurred only in patients with coronary artery disease was an unexpected finding. Although the atypical response was more frequent in the propranolol group, it was clearly not related to propranolol intake. We believe this response reflected the inability of the heart to increase output sufficient to increase blood pressure in the presence of decreased systemic vascular resistance. In the small group of thirty patients with coronary disease tested with isoproterenol we were unable to correlate the atypical response with any characteristic of the disease measured properatively (vessels involved, history of infarction, LVEDP, ejection fraction, etc.) or with intra or postoperative course. Failure of correlation was primarily the result of the small number of typical responders, only 10 out of 30. Conceivably the stress of a small dose of isoproterenol might provide useful prognostic information if applied to a larger group of patients selected for aortocoronary bypass graft operations.
Despite the reputed hazards of administration of propranolol to anesthetized patients, we previously found small intravenous doses of propranolol (0.3-0.4 mg repeated once when necessary) successful in treating 89% of 239 tachyarrhythmias, acutely precipitated during cardiac operations.'0 Only anesthetized patients who received single intravenous doses greater than 1.0 mg have encountered excessive bradycardia and hypotension. Our data on plasma levels after a 0.5 mg bolus supports the safety of this therapy. The peak level achieved was approximately 40 ng/ml ( fig. 3) depress aberrant pacemakers without complete block and without prolonged effects. When tachyarrhythmias recurred after successful treatment by a small dose, they did so in about 30-35 minutes. In those few instances when propranolol doses larger than 1.0 mg had been used, the excessive effect of propranolol could still be antagonized by a larger than usual dose of epinephrine or isoproterenol.
We have come to believe that withdrawal of propranolol more than 24 hours before coronary bypass operations may be more hazardous than beneficial. We suggest that twelve hours is sufficient if withdrawal is desired. We believe the risk of myocardial infarction or intractable arrhythmias after withdrawal is of greater consequence than the small degree of block which might persist at the time of anesthesia and which in any case could be overcome by isoproterenol if necessary. In addition, we believe propranolol when used in small intravenous doses is a safe and highly useful drug for the treatment of tachyarrhythmias precipitated during cardiovascular operations. The myocardial depressant activity of general anesthetics at the light level used during cardiac operations probably increases the effectiveness of propranolol and permits the successful therapy we observed with these small doses.
